Intestinal Research

IBD
Beyond the survey, to the ideal therapy for Asian: Ki Jae Jo, Jong Pil Im; Intest Res. 2023;21(3):280-282. Published online July 27, 2023; DOI: https://doi.org/10.5217/ir.2023.00075; Full text PubReader ePub PDF

Diagnosis, management, and prevention of infectious complications in inflammatory bowel disease: variations among Asian countries: Ji Eun Baek, Sung Wook Hwang; Intest Res. 2023;21(3):277-279. Published online July 27, 2023; DOI: https://doi.org/10.5217/ir.2023.00076; Full text PubReader ePub PDF

How have treatment patterns for patients with inflammatory bowel disease changed in Asian countries?: Jihye Park; Intest Res. 2023;21(3):275-276. Published online July 27, 2023; DOI: https://doi.org/10.5217/ir.2023.00061; Full text PubReader ePub PDF

Miscellaneous
JAK inhibitor, a new player for treatment-refractory microscopic colitis: Anne Druez, Simon Travis, Jean-François Rahier; Intest Res. 2023;21(3):411-412. Published online July 4, 2023; DOI: https://doi.org/10.5217/ir.2023.00030; Full text PubReader ePub PDF

IBD
Vaccination in patients with inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting: Su Bum Park, Kyeong Ok Kim, Hong Sub Lee, Chang Hwan Choi, Shu Chen Wei, Min Hu Chen, Katsuyoshi Matsuoka; Intest Res. 2023;21(3):363-374. Published online June 16, 2023; DOI: https://doi.org/10.5217/ir.2023.00015
Web of Science 1 Crossref 2; Full text PubReader ePub PDF Supplementary Material

Tumor
Clinical characteristics and risk factors related to polyposis recurrence and advanced neoplasm development among patients with non-hereditary colorectal polyposis: Jihun Jang, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim; Intest Res. 2023;21(4):510-517. Published online May 31, 2023; DOI: https://doi.org/10.5217/ir.2022.00139
Web of Science 1; Full text PubReader ePub PDF

Infection
Comparative outcomes of acute colonic diverticulitis in immunocompromised versus immunocompetent patients: a systematic review and meta-analysis: Jae Gon Lee, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Shin Hee Lee, Myung-Won You, Seong-Eun Kim; Intest Res. 2023;21(4):481-492. Published online May 31, 2023; DOI: https://doi.org/10.5217/ir.2023.00005
Web of Science 1 Crossref 1; Full text PubReader ePub PDF Supplementary Material

IBD
Animal models of inflammatory bowel disease: novel experiments for revealing pathogenesis of colitis, fibrosis, and colitis-associated colon cancer: Chan Hyung Lee, Seong-Joon Koh, Zaher A Radi, Aida Habtezion; Intest Res. 2023;21(3):295-305. Published online May 31, 2023; DOI: https://doi.org/10.5217/ir.2023.00029
Web of Science 5 Crossref 5; Full text PubReader ePub PDF

0. Concomitant ankylosing spondylitis with inflammatory bowel disease: Clinical significance in terms of clinical outcomes: Published online May 9, 2023

IBD
Corrigendum: Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study: Kyunghwan Oh, Hee Seung Hong, Nam Seok Ham, Jungbok Lee, Sang Hyoung Park, Suk-Kyun Yang, Hyuk Yoon, You Sun Kim, Chang Hwan Choi, Byong Duk Ye, on behalf of the Korean Association for the Study of Intestinal Diseases; Intest Res. 2023;21(2):273-273. Published online April 28, 2023; DOI: https://doi.org/10.5217/ir.2021.00173.e; Full text PubReader ePub PDF

First aid with color atlas for the use of intestinal ultrasound for inflammatory bowel disease in daily clinical practice: Jun Miyoshi, Hiromu Morikubo, Hiromi Yonezawa, Hideaki Mori, Tadakazu Hisamatsu; Intest Res. 2023;21(2):177-188. Published online April 28, 2023; DOI: https://doi.org/10.5217/ir.2023.00003
Web of Science 2 Crossref 2; Full text PubReader ePub PDF

Are the risks of colorectal cancer and biliary cancer really increased if patients with ulcerative colitis have primary sclerosing cholangitis?: Jung Wook Lee, Won Moon; Intest Res. 2023;21(2):171-173. Published online April 28, 2023; DOI: https://doi.org/10.5217/ir.2023.00049; Full text PubReader ePub PDF

Does caffeine have a double-edged sword role in inflammation and carcinogenesis in the colon?: Emiko Mizoguchi, Takayuki Sadanaga, Toshiyuki Okada, Takanori Minagawa, Jun Akiba; Intest Res. 2023;21(3):306-317. Published online April 20, 2023; DOI: https://doi.org/10.5217/ir.2022.00118
Crossref 1; Full text PubReader ePub PDF

Artificial intelligence in inflammatory bowel disease: implications for clinical practice and future directions: Harris A. Ahmad, James E. East, Remo Panaccione, Simon Travis, James B. Canavan, Keith Usiskin, Michael F. Byrne; Intest Res. 2023;21(3):283-294. Published online April 20, 2023; DOI: https://doi.org/10.5217/ir.2023.00020
Web of Science 4 Crossref 4; Full text PubReader ePub PDF

Serum albumin is the strongest predictor of anti-tumor necrosis factor nonresponse in inflammatory bowel disease in resource-constrained regions lacking therapeutic drug monitoring: Peeyush Kumar, Sudheer K. Vuyyuru, Prasenjit Das, Bhaskar Kante, Mukesh Kumar Ranjan, David Mathew Thomas, Sandeep Mundhra, Pabitra Sahu, Pratap Mouli Venigalla, Saransh Jain, Sandeep Goyal, Rithvik Golla, Shubi Virmani, Mukesh K. Singh, Karan Sachdeva, Raju Sharma, Nihar Ranjan Dash, Govind Makharia, Saurabh Kedia, Vineet Ahuja; Intest Res. 2023;21(4):460-470. Published online March 17, 2023; DOI: https://doi.org/10.5217/ir.2022.00128
Web of Science 1 Crossref 1; Full text PubReader ePub PDF Supplementary Material

Search